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Abstract
Background: Approximately 17 % of all fractures involve the distal radius. Two-thirds require reduction due to
displacement. High redislocation rates and functional disability remain a significant problem after non-operative
treatment, with up to 30 % of patients suffering long-term functional restrictions. Whether operative correction is
superior to non-operative treatment with respect to functional outcome has not unequivocally been confirmed.
The IlluminOss® System was introduced in 2009 as a novel, patient-specific, and minimally invasive intramedullary
fracture fixation. This minimally invasive technique has a much lower risk of iatrogenic soft tissue complications.
Because IlluminOss® allows for early mobilization, it may theoretically lead to earlier functional recovery and ADL
independence than non-operative immobilization. The main aim of this study is to examine outcome in elderly
patients who sustained a unilateral, displaced, extra-articular distal radius fracture that was treated with IlluminOss®.
Methods/design: The design of the study will be a multicenter, prospective, observational study (case series). The
study population comprises elderly (60 years or older; independent in activities of daily living) with a unilateral,
displaced, extra-articular distal radius fracture (AO/OTA type 23-A2 and A3) that after successful closed reduction
was fixed within 2 weeks after the injury with IlluminOss®. Critical elements of treatment will be registered, and
outcome will be monitored until 1 year after surgery. The Disabilities of the Arm, Shoulder, and Hand score will
serve as primary outcome measure. The Patient-Rated Wrist Evaluation score, level of pain, health-related quality of
life (Short Form-36 and EuroQoL-5D), time to ADL independence, time to activities/work resumption, range of
motion of the wrist, radiological outcome, and complications are secondary outcome measures. Health care
consumption and lost productivity will be used for a cost analysis. The cost analysis will be performed from a
societal perspective. Descriptive data will be reported.
Discussion: The results of this study will provide evidence on the effectiveness of operative treatment of patients
who sustained an extra-articular distal radius fracture with the IlluminOss® System, using clinical, patient-reported,
and societal outcomes.
Trial registration: The study is registered at the Netherlands Trial Register (NTR5457; 29-sep-2015).
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Background
Distal radius fractures are the second most common
osteoporotic fractures [1]. The number of hospitaliza-
tions due to these fractures in The Netherlands in
patients aged 50 years and older increased from 877 in
1997 to 2912 in 2009 [2]. In line with demographic de-
velopments, osteoporotic fractures including those of
the wrist can be expected to increase further in the
coming years, with a concomitant increased burden on
health care resources [3–5].
The current standard treatment for patients with a
displaced extra-articular distal radius fracture as men-
tioned in the Dutch treatment guideline is closed reduc-
tion and plaster cast immobilization for 4–6 weeks [6].
Non-operative treatment remains controversial due to
high dislocation rates (36–57 %) and often disappointing
functional recovery [6–11]. Immobilization may also induce
stiffness. Multiple studies have shown that comminuted
extra-articular distal radius fractures are characterized by
instability, and plaster immobilization will usually not pre-
vent substantial redisplacement [8, 12, 13].
Several operative procedures are used for extra-
articular distal radius fractures. In osteoporotic bone,
angular stable plates are widely used, whereas the inter-
est in and use of intramedullary devices is growing.
Potential advantages of modern intramedullary devices
could be the minimal surgical exposure for introduction
of the device and the low risk of implant-related soft
tissue irritation. This includes a reduced risk of tendon
injury and screw penetration into the joint, which are
the main problems of volar plating [14]. A recent litera-
ture review showed that intramedullary nailing gives a
comparable range of motion, functional outcome, and
grip strength as other fixation techniques, however the
0–50 % complication rate may raise concerns about the
role of intramedullary nailing [15]. In addition to in-
jury of the superficial radial nerve as most common
complication (occurring in 9.5 % of patients), irri-
tation from metalwork, tenosynovitis, and infection
occurred in 1-2 % of patients. New devices and
surgical techniques should be aimed at reducing the
risk of these complications.
The llluminOss® System is the first percutaneous,
patient-specific, fracture stabilization system [16]. Only
a small and percutaneous incision is required to in-
sert an inflatable balloon into the medullary canal.
The balloon, which spans the fracture is infused with
a light curable monomer. The monomer hardens in
situ by applying a visible light, resulting in a stable
and patient-specific implant that provides longitudinal
strength and rotational stability over the length of the
implant. Early functional after-treatment without add-
itional plaster immobilization is possible. The latter is
considered the main strength of this device over non-
operative treatment and conventional metal implants
[16].
The IO-WRIST study is designed to determine results
after treatment with IlluminOss®. Outcome will be moni-
tored as propagated by the distal radius working groups
of the International Society for Fracture Repair and the
International Osteoporosis Foundation [17]. This study
primarily aims to examine the effect of operative
treatment using the IlluminOss® System on the DASH
(Disabilities of the Arm, Shoulder, and Hand) score in
elderly patients who sustained a unilateral, displaced,
extra-articular distal radius fracture. Secondary objec-
tives are to examine the effect on functional outcome,
the level of pain, health-related quality of life, the
time to regaining independence in activities of daily
living (ADL), the resumption of work/ADL, range of
motion of the wrist, the time to radiographic healing,
the rate of complications with associated secondary




The IO-Wrist study is a multicenter, prospective, obser-
vational study (i.e., case series). As the intervention stud-
ied is a relatively new technique and there is a lack of
published evidence a case series was preferred over a
study comparing the intervention with a control group.
The following four hospitals in The Netherlands will
participate: 1) Albert Schweitzer Hospital, Dordrecht; 2)
Amphia Hospital, Breda; 3) Deventer Hospital, Deventer;
and 4) Erasmus MC, Rotterdam. The study is registered
at the Netherlands Trial Register (NTR5457), registra-
tion date September 29, 2015.
Recruitment and consent
Eligible persons who present to the Emergency Depart-
ment (ED) with a unilateral, displaced, extra-articular
distal radius fracture will be informed about the study
after the fracture has been reduced or as early as possible
after operative treatment. They may receive the informa-
tion at the ED or upon admission at the surgical ward.
The clinical investigator, an assistant, or the attending
physician will explain the study, and give the patient writ-
ten information and a consent form. Patients meeting
all eligibility criteria will be included as soon as pos-
sible. This can be done while patients are still at the ED
or when they return to the outpatient department at
2 weeks after surgery.
In order to reduce bias as much as possible, the
follow-up measurements by the clinical investigator or
research assistant will be performed using a standardized
protocol. Evaluation of fracture healing from radiographs
will be done by two (independent) trauma surgeons
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independently. Any disagreement will be discussed and
until consensus is reached.
Study population
All elderly persons aged 60 years or older, who were in-
dependent in activities of daily living before the injury,
presenting to the ED with a unilateral, displaced, extra-
articular distal radius fracture (AO/OTA type 23-A2 and
A3) [18] and treated with IlluminOss® will be considered
eligible for inclusion. The fracture will be classified on
lateral (preferably lateral carporadial) and anteroposter-
ior (AP) radiographs.
The inclusion criteria are:
1. Adult men or women with an age of 60 years or older
2. A unilateral, displaced, extra-articular distal radius
fracture (AO/OTA type 23-A2 or A3), as confirmed on
X-ray (lateral (preferably lateral carporadial) and AP)
3. Capable of independent activities of daily living prior
to index injury*
4. Closed reduction and intramedullary fixation using
the IlluminOss® System within 14 days after trauma
5. Provision of informed consent by patient.
* This will be assessed using a simple yes/no question
concerning their independence.
The exclusion criteria are:
1. Additional traumatic injuries if this affects treatment,
rehabilitation, or function of the affected wrist
2. A pathological, recurrent, or open (i.e., Gustilo-
Anderson grade II or III) fracture
3. An impaired wrist function at the affected side) due
to arthrosis, rheumatoid disorder, or neurological
disorder prior to the injury
4. A bone disorder (excluding osteoporosis), that may
impair bone healing (e.g., osteomalacia, renal
osteodystrophy, or Paget’s disease)
5. Patient is unwilling or unable to comply with the
after-care protocol and follow-up visit schedule
6. Insufficient understanding of the Dutch language for
adequate comprehension of the treatment
information or rehabilitation program, as judged by
the attending physician or researcher
7. Participation in another surgical intervention or
drug study.
Intervention
Following successful closed reduction, patients will
undergo fixation with the IlluminOss® System (Illumi-
nOss® Medical, East Providence, RI, USA), using a
standardized protocol and the manufacturer’s guidelines
(Fig. 1). During the procedure, the fracture is reduced
and stabilized. A customized, inflatable, thin walled
polyethylene terephthalate (PET; Dacron) balloon is
mounted on an insertion catheter. The small diameter
compressed balloon (~3.5 mm) is inserted into the
medullary canal spanning the fracture site. Next, the
delivery sheath is removed, uncovering the balloon. The
balloon is then infused with a biocompatible photo-
dynamic liquid monomer via a syringe, causing the
balloon to expand. The inflated implant conforms to the
shape of the canal and curves from the entry at the
radial styloid into the canal. The formed arc within the
radial box acts as a support structure to the floor of the
articular surface and contributes to a transverse reduc-
tion force. The bone is visualized under fluoroscopy to
ensure that the fracture has been properly reduced, with
the balloon in the appropriate position, fully inflated and
contacting the inner diameter of the bone. Upon activa-
tion of the light system (Blue Wave 75 VT Photo-
dynamic Light Box), the photo initiator in the monomer
rapidly polymerizes and hardens in situ to form a strong
hardened nail that provides articular support and canal
and rotational stability. This aids fracture healing by
primary callous formation and remodeling.
Patients will receive antibiotics prophylaxis according
to the local protocol. They are discharged with either a
double bandage or a soft cast. No post-operative mobility
restrictions will apply, and patients will be allowed to use
their wrist as tolerated immediately.
Relevant details of surgery will be collected (e.g., length
and diameter of the balloon, time between injury and
surgery, duration of the operation) for assessing the effect
on outcome. There will be no restriction in the use of
(analgetic) medication or other kind of intervention.
Details on the use of analgesics will be recorded. Details of
physical therapy and rehabilitation will also be recorded.
They will not be standardized as evidence favoring a
particular approach is not available. Bone growth stimula-
tors (electrical, ultrasound, or magnetic) are prohibited.
All participating surgeons have attended a technique-
oriented training course and performed multiple proce-
dures before commencing the study.
Outcome measures
The primary outcome measure is the Disabilities of the
Arm, Shoulder and Hand outcome measure (DASH).
This questionnaire is validated and is completed by
patients. It reflects the disability experienced by patients
with an upper-limb disorder, and is used for monitoring
changes in symptoms and function over time [19–22].
The DASH disability/symptom score is the sum of
responses to 30 items (scored 1-5), which test a) the
degree of difficulty in performing a variety of physical
activities (21 items); b) the severity of pain, activity-
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related pain, tingling, weakness, and stiffness (5 items);
and c) the effect on social activities, work, sleep, and
self-image (4 items). The total score ranges from zero
(no disability) to 100 points (severe disability). At
least 27 of the 30 items must be completed. A vali-
dated Dutch version is available [23]. The DASH
optional modules for Work and high performance
Sport/Music (both 4 items, scored 1–5) will also be
completed. The score can only be calculated if all
items are completed.
The secondary outcome measures are:
 Patient-Rated Wrist Evaluation (PRWE)
 Pain level at both sides (VAS)
 Health-related quality of life: Short Form-36 (SF-36)
and EuroQoL-5D (EQ-5D)
 Time to regaining independence in Activities of
Daily Living (ADL)
 Resumption of work and other activities of daily
living




 Health care consumption with associated costs
 Productivity loss with associated costs
The Patient-Rated Wrist Evaluation (PRWE) measures
functional outcome in patients diagnosed with a distal
radius fracture [24]. In this 15-item questionnaire,
patients are asked to rate the level of pain and disability
in their wrist from zero (no pain/difficulty) to 10
(worst pain/unable to do) [25, 26]. The PRWE
consists of a 5-item Pain subscale, a 6-item Specific
Activities subscale, and a 4-item Usual Activities
subscale. Responses to the individual subscales are
summed. The total score for wrist pain and disability
(100 points) is computed by dividing the sum of the
ten functional items by two and adding that subtotal
(50 points) to the score for the pain subscale
(50 points). This provides a score that ranges from 0
(no pain or disability) to 100 (high level of pain or
disability). A validated Dutch version is available [27].
Fig. 1 Using the IlluminOss® System for fixating a distal radius fracture*. a 1.5–2.0 cm incision over the radial styloid process, between the first
and second extensor compartment to reach the periosteum. The superficial branches of the radial nerve are protected. b Access to the medullary
canal and insertion of a 1.5 mm guide-wire. c Correct position is verified by intra-operative fluoroscopy. d Flexible balloon catheter is
placed intramedullary over the guide-wire spanning the fracture. e Infusion of liquid monomeric material and expansion of the balloon
conforming to the patient’s unique medullary canal. f Verification of adequate fracture reduction, correct balloon position, and balloon
expansion. g Polymerization (hardening) of the infused monomer by applying visible (436 nm) light, creating a patient specific intramedullary implant.
* (Photographs and radiographs are used with permission of the patient)
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Pain level will be assessed using a 100 mm Visual
Analog Scale (VAS), ranging from zero (no pain) to 100
(the worst pain possible). Scores for the affected and
contralateral side will both be recorded. At each follow-
up visit, patients will also be requested to list the type
and quantity of analgesics taken.
The Short Form-36 (SF-36) is a validated generic
health survey. The 36 items represent eight health
domains, which are combined into a Physical Compo-
nent Summary (PCS) and a Mental Component Sum-
mary (MCS) [21, 22, 28–30]. The eight health domains
are physical functioning (PF; 10 items), role limitations
due to physical health (RP; 4 items), bodily pain (BP; 2
items), general health perceptions (GH; 5 items), vitality,
energy, or fatigue (VT; 4 items), social functioning (SF; 2
items), role limitations due to emotional problems (RE;
3 items), and general mental health (MH; 5 items). The
score for each domain ranges from 0 to 100 points. They
are normalized to and compared with norm scores of
the general population of the United States (1998).
Herein, each scale has an average of 50 points and a
standard deviation of 10 points. A lower SF-36 score
indicates poorer quality of life. A validated Dutch version
is available [31].
The EuroQol-5D (EQ-5D) questionnaire is validated
for measuring health-related quality of life [21, 22, 32,
33]. EQ-5D is recommended as quality of life instrument
for trauma patients [34, 35]. It consists of two parts. The
EQ-5D descriptive system has five questions (scored 1–
3) regarding problems with mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression. The
resulting scores are converted to a utility score that
ranges from zero to one; a lower score reflects a poorer
quality of life. The EQ VAS is a self-rated health status
measure, consisting of a vertical 100 mm visual analog
scale from zero to 100. A validated Dutch version is
available [33].
The time to regaining ADL independence will be asked
as a single question. The level of work/ADL resumption
will be measured using a numeric rating scale.
The range of motion (ROM) of both wrists (i.e., palmar
flexion and dorsal extension, ulnar deviation and radial
deviation, pronation and supination) will be measured
using a goniometer. The loss of ROM will be calculated as
ROM affected side - ROM contralateral side.
Radiographic evaluation will be done using routinely
obtained radiographs. The degree of radial inclination,
volar/dorsal tilt and ulnar variance, the amount of com-
minution, and the radial length will be measured directly
in the digital Picture Archiving and Communication
System (PACS) of the participating hospital on standard
AP, lateral carporadial, or lateral wrist X-rays. Radiographs
will be made using a standardized protocol; 1) for the AP
radiographs, the shoulder should be held in 90° abduction,
the elbow in 90° flexion, and the wrist in neutral position;
2) for the lateral X-rays, the shoulder should be held in a
neutral position and the elbow in 90° flexion; 3) for the
lateral carporadial radiographs, the lower arm should be
positioned on a 20–25° angled wedge.
Radiographic healing and alignment of the distal radius
will be evaluated using X-rays. The treating physician and
two independent experts will assess the Lidström score
for the repeated X-rays of the wrist blinded from the first
assessment [36]. X-rays will be blinded and radiographic
evaluation will be done by two experts independently. Any
discrepancy will be resolved in a consensus meeting.
The following complications will be collected from the
patients’ hospital records; 1) skin problems (threatened
skin, necrosis); 2) Surgical site infection [37]; 3) radial
nerve pathology; 4) vascular injury (hemorrhage, injury
to the radial or ulna artery); 5) tendon pathology
(abductor pollicis brevis/longus, extensor carpi radialis
brevis/longus, extensor pollicis longus); 6) compartment
syndrome; 7) secondary dislocation (loss of length,
angulation, or rotation); 8) implant failure (balloon
breakage); 9) non-union/pseudarthrosis (i.e., no healing
or progress towards healing visible at 6 months after
surgery); 10) malalignment severe enough to treat
surgically; 11) CRPS type I; 12) systemic, generic or
other complications.
Secondary intervention within 1 year of surgery will be
collected from the patients’ hospital records. Only in-
terventions aimed at relieving pain, treating infection,
promoting fracture healing, or improving function will
be recorded. They will be categorized as 1) drug treat-
ment (oral or intraveneous antibiotics, other); 2) surgical
treatment (incision and drainage, revision osteosynthesis
(plate osteosynthesis, intramedullary nail or other),
implant removal, other).
A custom-made questionnaire will be designed to collect
details of health care consumption and work absenteeism
(i.e., production loss). Health care use associated with
diagnosis, treatment, and rehabilitation will be collected.
This includes medical specialist care, hospitalization,
medication, nursing care, physical therapy, and general
practice care [21].
The following data will be collected in order to de-
scribe the population and intervention:
a) Patient characteristics: age, gender, American Society
of Anesthesiologists’ (ASA) classification, tobacco use,
comorbidities, medication use, dominant side, sports
activities prior to injury, work prior to injury,
household composition, and ADL pre-injury.
b) Injury characteristics: mechanism of injury,
affected side, AO fracture classification [38],
and additional injuries.
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c) Intervention characteristics: time between injury and
surgery, length and diameter of PET balloon used,
duration of surgery, peroperative complications,
admission duration at the Intensive Care Unit and in
hospital, type and duration of immobilization
(including the use of a sling or collar and cuff ),
time between trauma and the first physical
therapy session, and the duration of physical
therapy (i.e., total number of sessions).
Study procedures
Patients will be followed for 1 year. Follow-up visits are
scheduled at 2 weeks, 6 weeks, 3 months, 6 months,
and 12 months after index surgery. These visits are
standard of care for patients with a distal radius
fracture. Table 1 shows an overview of the follow-up
schedule, including the accepted windows around
each visit.
During these regular clinical follow-up visits, AP and
lateral radiographs are made for determining radiographic
healing and malalignment.
At each planned visit, the clinical investigator (or a
research assistant) will document complications and sec-
ondary interventions, and will check information within
the patients’ hospital files. At the last visit, all planned
secondary interventions will also be recorded.
At each planned visit, a physician, clinical investigator,
or research assistant will measure the range of motion of
the wrist using a goniometer. In addition, patients will
be requested to complete a set of questionnaires (DASH,
PRWE, VAS for pain, SF-36, EQ-5D, ADL/work, health
care consumption, and production loss).
Sample size calculation
For case series, a generally accepted assumption is that
introducing and implementing a (relatively new) surgical
technique requires 30 patients [39]. A formal sample size
calculation for this study is based on the DASH score
(primary outcome measure). The minimal important
change for the DASH score is 10 points [19]. Based on
literature data we expect a mean DASH of 23 (SD 19) in
non-operatively treated patients [40, 41]. In order to
detect a 10-point improvement (mean 13, SD 10) in
patients treated with IlluminOss® with a two-sided α of
0.05 and a 90 % power (β = 0.10), at least 38 patients are
needed. Anticipating 10–15 % loss to FU and 10 %
mortality, 50 patients will be enrolled.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS)
version 21 or higher (SPSS, Chicago, Ill., USA) will be
used for statistical analysis. The STrengthening the
Reporting of OBservational studies in Epidemiology
Table 1 Schedule of events
Radiographs & Events Screening Enrolment Baseline Per/Post 2 weeks 6 weeks 3 months 6 months 12 months
surgery (10–16 days) (5–7 weeks) (11–15 weeks) (5–7 months) (12–14 months)




Surgical Report Form X
Clinic FU X X X X X
Range of Motion X X X X X
DASH X X X X X
PRWE X X X X X
Pain (VAS) X X X X X
SF-36 X X X X X
EQ-5D X X X X X
ADL independence X X X X X
Work/ADL resumption X X X X X
Complications X X X X X
Secondary Interventions X X X X X
Health Care Use X X X X X
Early Withdrawal b b b b b
aThe AP and lateral X-rays will be used for determining radiographic healing
bOnly applicable at time of withdrawal
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(STROBE) guidelines will apply to data reporting. If
necessary, missing values will be replaced using multiple
imputation following the predictive mean matching
method, using ten imputations. The Shapiro-Wilk test
will be used for testing normality of continuous data. All
statistical tests will be two-sided, and a p-value <0.05
will be used as threshold of statistical significance.
Descriptive analysis will be performed in order to report
baseline and outcome data. Data will be reported as mean
with SD (continuous, parametric data), as median with
first and third quartile (continuous, non-parametric
data), or as number with frequency (categorical data).
A Wilcoxon Signed Rank test will be applied for compar-
ing continuous outcome scores at 1 year with those at
their first measurement.
Depending on the variability of covariates, multivari-
able analysis may be performed. A linear mixed-effects
regression model will be made to model the relation
between specific covariates and the outcome measures
that are recorded repeatedly (i.e., DASH and other
PROMs). This multilevel model will include fixed effects
for covariates like involvement of the dominant side,
gender, and age if deemed necessary. These confounders
will be selected based upon literature data and by
eyeballing the descriptive statistics. The beta values will
be reported with their 95 % confidence interval and
p-value. Estimated marginal mean will be computed
and reported per follow up moment.
For the continuous data determined only once (e.g.,
time to radiographic healing), a multivariable linear re-
gression model may be developed, with the outcome
measure as dependent variable. Potentially confounding
variables will be entered as covariate. Beta values will be
reported with 95 % confidence interval and p-value.
For the categorical data, a multivariable logistic regres-
sion model will be developed, with the outcome measure
as dependent variable. Potentially confounding variables
will be entered as covariate. Odds ratio’s will be reported
with 95 % confidence interval and p-value.
The economic evaluation will include costs for health
care as well as for lost productivity. Direct and indirect,
medical and non-medical cost will be measured as indi-
cated in the Dutch guidelines for economic evaluations,
using standard, published cost prices where possible
[42]. Costs for lost productivity will also be calculated.
Discussion
Despite the frequent occurrence of distal radius frac-
tures, treatment is still at debate. The ultimate goal of
treating a distal radius fracture is to restore full wrist
function as early as possible. Full range of motion in the
wrist declines with disuse and the introduction of early
motion following a fracture is critical for the early
restoration of normal function, but also for regaining
ADL independence. Especially the latter is considered
the main strength of the IlluminOss® System. The IO-
Wrist study is aimed at determining the effect of opera-
tive treatment of distal radius fractures using the Illumi-
nOss® System. Treating patients with this device is
expected to result in good and fast functional recovery
(i.e., low DASH and high PRWE scores). When compar-
ing outcome with published data on non-operative treat-
ment (i.e., closed reduction and 4–6 weeks plaster cast
immobilization, with surgical intervention only if sec-
ondary dislocation occurs), we expect similar outcome
at 1 year post-injury. However, improved DASH scores
are expected to be noticeable until 6 months after treat-
ment initiation, reflecting faster functional recovery in
the operative group. Patients operated with IlluminOss®
are expected to regain independence sooner and there-
fore to consume less health care. Improved recovery as
well as less total health care use would justify higher
costs for the initial surgery. As far as we know, this is
the first high-quality study that will evaluate outcome
after treating patients with an extra-articular distal ra-
dius fracture operated with the IlluminOss® System,
using patient-reported, clinical, and economic outcomes.
Four hospitals in the Netherlands participate in this
study. The first patient was included on August 31,
2015. Inclusion is expected to be completed within a
year. With a follow-up of 1 year data presentation is
expected by the end of 2017.
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